20岁网红Braden Eric Peters（网名Clavicular）在马萨诸塞州因强奸罪和毒品犯罪被起诉1。这位在极端审美改善趋势"looksmaxxing"中有推波助澜作用的网红面临终身监禁的可能1。他定于2025年10月14日在Cape Cod出庭受审1。指控涉及2025年5月在马萨诸塞州发生的犯罪行为1，包括强奸罪、给他人下药用于性交的重罪以及向未成年人提供酒精的轻罪1。
除马萨诸塞州的刑事指控外，Peters还面临来自佛罗里达州一名少女的民事诉讼1。根据诉讼，该少女在事件发生时仅16岁1。民事诉讼称Peters向该少女注射了含有甲基苯丙胺的Aqualyx（一种未获FDA批准的物质）两次1。Peters在社交媒体X平台上回应了这些指控，声称该少女"trying to get my attention in anyway possible, a lawsuit?"并称其"petty"1。
Peters此前已有多起法律纠纷。他在3月因在直播中射杀一只已死亡的鳄鱼而在佛罗里达被控非法持枪，后通过认罪交易获得6个月缓刑和20小时无偿社区服务1。同月，他与24岁女友Violet Marie Lentz因涉嫌殴打一名19岁女性而在佛罗里达被控电池罪1。根据《纽约时报》报道，Peters在2月时月收入超过10万美元1，在线粉丝超过100万1。
Braden Eric Peters, the 20-year-old social media personality known online as Clavicular, has been charged with rape and drug-related crimes in Massachusetts 1. Peters, who helped popularize the "looksmaxxing" extreme aesthetic enhancement trend, faces felony charges that could result in a life sentence 1. He is scheduled to appear in court on October 14, 2025, at Cape Cod 1. The charges stem from alleged crimes committed in May 2025 and include rape, administering drugs for sexual purposes, and furnishing alcohol to a minor 1.
According to a separate civil lawsuit filed by a teenage girl from Florida, Peters injected her twice with an unapproved substance containing methamphetamine known as Aqualyx 1. The plaintiff was 16 years old at the time of the alleged incidents 1. Peters has responded on X platform, dismissing the girl's claims as attention-seeking and describing the lawsuit as "petty" 1.
This is not Peters' first legal trouble. In March 2025, he pleaded guilty to illegal firearm possession in Florida after shooting a dead alligator on livestream, receiving six months of probation and 20 hours of community service 1. That same month, Peters and his 24-year-old girlfriend, Violet Marie Lentz, were charged with battery in Florida for allegedly assaulting a 19-year-old woman 1. According to reporting from The New York Times, Peters was earning over $100,000 monthly as of February 2025, and maintains a following exceeding one million on X 1.
评论
还没有评论，欢迎留下第一条。